Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 449–456 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Annexon Inc. ANX007 vs SYFOVRE - (ARROW) Geographic atrophy (GA) Phase 3 Trial Planned ANX007 intravitreal SYFOVRE intravitreal Opthalmic
Annexon Inc. ANXV Retinal vein occlusion (RVO) Phase 2 Data Released Intravenous Opthalmic
Annexon Inc. ANX005 - (wAIHA) Warm autoimmune hemolytic anemia (WAIHA) Phase 2 Trial Discontinued Intravenous Hematology
Annexon Inc. Tanruprubart (ANX005) Guillain-Barré Syndrome (GBS) BLA Filing Data Released Intravenous Neurology
Annexon Inc. ANX007 - (ARCHER-II) Geographic atrophy Phase 2 Enrollment Conclusion Intravitreal Opthalmic
Annexon Inc. ANX005 Huntington’s disease (HD) Phase 2/3 Trial Planned Intravenous Neurology
Annovis Bio Inc. Buntanetap (ANVS401) Alzheimer’s disease (AD) Phase 3 Enrollment Initiation Oral Neurology
Annovis Bio Inc. Buntanetap Parkinson's Disease (PD) Phase 3 Ongoing Oral Neurology